Kajiwara A, Kita A, Saruwatari J, Oniki K, Morita K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.
Higher risk of sulfonylurea-associated hypoglycemic symptoms in women with type 2 diabetes mellitus
Clin Drug Investig. 2015;35(9):593-600

Morita K, Masuda N, Tanaka T, Saruwatari J, Oniki K, Kajiwara A, Otake K, Ogata Y, Nakagawa K.
A functional variant in the γ-glutamyl transferase (GGT) 1 gene is associated with airflow obstruction in smokers
Clin Chem Lab Med. in press.

Tabata N, Hokimoto S, Akasaka T, Yuichiro A, Sakamoto K, Yamamoto E, Tsujita K, Izumiya Y, Yamamuro M, Kojima S, Koichi K, Kumagae N, Morita K, Oniki K, Nakagawa K, Matsui K, Ogawa H.
Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation
J Cardiol. in press.

Hokimoto S, Akasaka T, Tabata T, Arima Y, Tsujita K, Sakamoto K, Kaikita K, Morita K, Kumagae N, Yamamoto E, Oniki K, Nakagawa K, Ogawa H.
Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy
Thromb Res. 2015;135(6):1081-6

Morita K, Masuda N, Oniki K, Saruwatari J, Kajiwara A, Otake K, Ogata Y, Nakagawa K.
Association between the aldehyde dehydrogenase 2*2 allele and smoking-related chronic airway obstruction in a Japanese general population: A pilot study
Toxicol Lett. 2015;236(2):117-22.

Nakagawa K, Kajiwara A.
Female sex as a risk factor for adverse drug reactions.
Nippon rinsho. Japanese journal of clinical medicine. 2015;73(4):581-5

Marume K, Hokimoto S, Tabata N, Akasaka T, Tsujita K, Sakamoto K, Yamamoto E, Yamamuro M, Kaikita K, Oniki K, Nakagawa K, Ogawa H.
Intraprocedural thrombotic event during coronary intervention depends on CYP2C19 genotype and is a predictor of future clinical event
Int J Cardiol. 2015;187:231-3.

Sueta D, Hokimoto S, Enomoto K, Ono T, Tabata T, Kajiwara I, Kaikita K, Saruwatari J, Oniki K, Nakagawa K, Ogawa H.
A case of repetitive and simultaneous stent thrombosis
Int J Cardiol. 2015;186:210-2.

Jinnouchi H, Morita K, Takahiro T, Kajiwara A, Kawata Y, Oniki K, Saruwatari J, Nakagawa K, Otake K, Ogata Y, Yoshida A, Hokimoto S, Ogawa H.
Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy
Cardiovasc Diabetol. 2015;14(1):49.

Kajiwara A, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Morita K, Oniki K, Saruwatari J & Nakagawa K.
Safety analysis of zolpidem in elderly subjects 80 years of age or older: Adverse event monitoring in Japanese subjects.
Aging & Mental Health. in press. 

Morita K, Saruwatari J, Tanaka T, Oniki K, Kajiwara A, Otake K, Ogata Y, Nakagawa K.
Associations between the common HNF1A gene variant p.I27L (rs1169288) and risk of type 2 diabetes mellitus are influenced by weight.
Diabetes Metab. 2015;41(1):91-4.

Hokimoto S, Tabata N, Akasaka T, Arima Y, Kaikita K, Morita K, Kumagae N, Oniki K, Nakagawa K, Ogawa H.
Gender Differences in Impact of CYP2C19 Polymorphism on Development of Coronary Artery Disease.
J Cardiovasc Pharmacol. 2015;65(2):148-52. 

Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K.
Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsy.
Neuropsychiatr Dis Treat. 2015;11:1007-14. 

Arima Y, Hokimoto S, Akasaka T, Mizobe K, Oniki K, Nakagawa K, Ogawa H.
Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina.
J Cardiol. 2015;65(6):494-500